Venture Capital Investors

Qiming Ventures

Qiming Ventures is a VC firm that helps tech entrepreneurs.

Venture Investor Overview

Venture Investor
Qiming Ventures
Status
Active
Investor Type
Venture Capital
Activity Level
63 transactions
Funds Raised
At least $2.8 billion
Industry Focus
Biopharmaceutical
Blockchain
Digital Media & VR & AR
Healthcare IT
Healthcare Services
Manufacturing
Medical Devices & Instruments
Semiconductors
Software

Contact Information

Contact
Gary Rieschel
Title
Managing Partner
Mailing Address
Jinmao Tower 88 Century Blvd. 3906
Shanghai, 200121
China
Phone
+86 21 6101 6522
Website
www.qimingventures.com
Email Address
[email protected]

Background Information

Overview
At Qiming we build lasting relationships with you - China's best new entrepreneurs; we invest in you and in your vision of creating value; and we bring together our whole team and network of veteran Chinese and global executives and investors to help you achieve long term success.
Profile
Qiming Ventures LinkedIn Company Profile
Social Media
Qiming Ventures Company Twitter Account
Company News
Qiming Ventures News
Facebook
Qiming Ventures on Facebook
YouTube
Qiming Ventures on YouTube
Last Transaction
10/12/2023

Transaction History

Our records indicate that Qiming Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Account Labs
10/12/2023
$7,700,000
LTZ Therapeutics
5/31/2023
$10,000,000
DeepWay
3/28/2023
$5,810,000
Allorion Therapeutics
3/10/2023
$50,000,000
TandemAI
3/1/2023
$35,000,000
OriCell Therapeutics
2/28/2023
$45,000,000
Soda Health
9/13/2022
$25,000,000
InSilico Medicine
8/11/2022
$95,000,000
OriCell Therapeutics
8/1/2022
$120,000,000
GluBio Therapeutics
8/1/2022
$22,000,000
Auron Therapeutics
7/20/2022
$48,000,000
Boulder Care
6/10/2022
$36,000,000
InSilico Medicine
6/6/2022
$60,000,000
BUD
5/23/2022
$36,800,000
AskGene Pharma
5/9/2022
$20,000,000
InfStones
3/21/2022
$33,000,000
BUD
2/24/2022
$15,000,000
Ceptur Therapeutics
1/28/2022
$75,000,000
Mauna Kea Semiconductors
1/8/2022
$12,800,000
Korro Bio
1/7/2022
$116,000,000
HilleVax
9/9/2021
$135,000,000
Alamar Biosciences
9/9/2021
$80,000,000
InfStones
8/24/2021
$10,000,000
Umoja Biopharma
6/16/2021
$210,000,000
LetsGetChecked
6/9/2021
$150,000,000
Ventyx Biosciences
3/10/2021
$114,000,000
Kira Pharmaceuticals
1/8/2021
$53,500,000
Umoja Biopharma
11/20/2020
$53,000,000
Elevation Oncology
11/19/2020
$65,000,000
Kira Pharmaceuticals
11/16/2020
$46,000,000
Talaris Therapeutics
10/7/2020
$115,000,000
InventisBio
9/30/2020
$147,000,000
Korro Bio
9/11/2020
$91,500,000
Korro Bio
9/10/2020
$91,500,000
Connect Biopharmaceuticals
8/26/2020
$115,000,000
Elevation Oncology
7/22/2020
$32,500,000
LetsGetChecked
5/7/2020
$71,000,000
Element Science
3/4/2020
$145,600,000
Jasper Therapeutics
12/10/2019
$35,000,000
Icosavax
10/4/2019
$51,000,000
Amphivena Therapeutics
9/25/2019
$62,000,000
InSilico Medicine
9/16/2019
$37,000,000
Platelet Biogenesis
9/10/2019
$26,000,000
Mafengwo
5/24/2019
$250,000,000
Talaris Therapeutics
4/19/2019
$100,000,000
Nuvaira
2/12/2019
$79,000,000
Schrodinger
1/8/2019
$85,000,000
Cadent Therapeutics
11/16/2018
$40,000,000
Cardialen
10/11/2018
$17,000,000
Madaket Health
7/24/2018
$10,000,000
CastBox
4/26/2018
$13,500,000
Twine Health
11/4/2017
$1,500,000
CastBox
10/13/2017
$16,000,000
JingChi
9/27/2017
$52,000,000
TigerGraph
9/20/2017
$31,000,000
Kezar Life Sciences
7/26/2017
$50,000,000
Platelet Biogenesis
6/9/2017
$10,000,000
ZappRx
4/21/2017
$25,000,000
Connect Biopharmaceuticals
1/27/2017
$20,000,000
ACEA Biosciences
11/10/2015
$30,000,000
LanzaTech
3/26/2014
$60,000,000
OriGene Technologies
3/21/2013
$21,300,000
Appconomy
12/20/2011
$10,000,000

 

Investor Contacts

Title
Name
Email & Social
Managing Partner
William Hu
  William Hu LinkedIn Profile  William Hu Twitter Account  William Hu News  William Hu on Facebook
Managing Partner
Duane Kuang
  Duane Kuang LinkedIn Profile  Duane Kuang Twitter Account  Duane Kuang News  Duane Kuang on Facebook
Managing Partner
Nisa Leung
  Nisa Leung LinkedIn Profile  Nisa Leung Twitter Account  Nisa Leung News  Nisa Leung on Facebook
Managing Partner
Gary Rieschel
  Gary Rieschel LinkedIn Profile  Gary Rieschel Twitter Account  Gary Rieschel News  Gary Rieschel on Facebook

 

Funds

Our database includes the following fund closing(s) for Qiming Ventures. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Qiming Venture Partners Fund VII
4/2/2020
$1,200,000,000
Fund V
1/26/2016
$650,000,000
Fund IV
6/30/2014
$500,000,000
Fund III
6/30/2011
$450,000,000

 

Portfolio Companies

Qiming Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Account Labs
ACEA Biosciences
Alamar Biosciences
Allorion Therapeutics
Amphivena Therapeutics
Appconomy
AskGene Pharma
Auron Therapeutics
Boulder Care
BUD
Cadent Therapeutics
Cardialen
CastBox
Ceptur Therapeutics
Connect Biopharmaceuticals
DeepWay
Element Science
Elevation Oncology
GluBio Therapeutics
HilleVax
Icosavax
InfStones
InSilico Medicine
InventisBio
Jasper Therapeutics
JingChi
Kezar Life Sciences
Kira Pharmaceuticals
Korro Bio
LanzaTech
LetsGetChecked
LTZ Therapeutics
Madaket Health
Mafengwo
Mauna Kea Semiconductors
Nuvaira
OriCell Therapeutics
OriGene Technologies
Platelet Biogenesis
Schrodinger
Soda Health
Talaris Therapeutics
TandemAI
TigerGraph
Twine Health
Umoja Biopharma
Ventyx Biosciences
ZappRx

 

 

 

 

Browse more venture capital investors:

Qiming Venture Partners USA | Qingdao Ocean Investment Group Co Ltd

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.